Kommentar zu den Leitlinien (2023) der ESC zum Management kardiovaskulärer Erkrankungen bei Patienten mit Diabetes

Nikolaus Marx; Dirk Müller-Wieland; Christine Espinola-Klein; Martin Halle; Annette Birkenhagen; Patrick Diemert; Felix Mahfoud; Harm Wienbergen; Katharina Schütt

doi:10.1007/s12181-024-00689-6

Kommentar zu den Leitlinien (2023) der ESC zum Management kardiovaskulärer Erkrankungen bei Patienten mit Diabetes

Translated title of the contribution: Comments on the guidelines (2023) of the ESC on the management of cardiovascular diseases in patients with diabetes

Nikolaus Marx
, Dirk Müller-Wieland
, Christine Espinola-Klein
, Martin Halle
, Annette Birkenhagen
, Patrick Diemert
, Felix Mahfoud
, Harm Wienbergen
, Katharina Schütt

Chair of Preventive Sports Medicine and Sports Cardiology

Research output: Contribution to journal › Article › peer-review

Abstract

Patients with diabetes mellitus exhibit an increased risk for the development of cardiovascular diseases and the presence of both comorbidities has a major impact not only on the prognosis but also the implementation of evidence-based treatment to reduce the cardiovascular risk. The new 2023 guidelines of the European Society of Cardiology (ESC) provide firm evidence-based recommendations for the management of cardiovascular diseases in patients with diabetes. The most relevant aspects of these guidelines are summarized in the following overview article.

Translated title of the contribution	Comments on the guidelines (2023) of the ESC on the management of cardiovascular diseases in patients with diabetes
Original language	German
Pages (from-to)	256-265
Number of pages	10
Journal	Kardiologie
Volume	18
Issue number	3
DOIs	https://doi.org/10.1007/s12181-024-00689-6
State	Published - Jun 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s12181-024-00689-6

Cite this

@article{eeedfff667ab4bcbbaf9305f872e98ac,

title = "Kommentar zu den Leitlinien (2023) der ESC zum Management kardiovaskul{\"a}rer Erkrankungen bei Patienten mit Diabetes",

abstract = "Patients with diabetes mellitus exhibit an increased risk for the development of cardiovascular diseases and the presence of both comorbidities has a major impact not only on the prognosis but also the implementation of evidence-based treatment to reduce the cardiovascular risk. The new 2023 guidelines of the European Society of Cardiology (ESC) provide firm evidence-based recommendations for the management of cardiovascular diseases in patients with diabetes. The most relevant aspects of these guidelines are summarized in the following overview article.",

keywords = "Cardiovascular disease, Diabetes mellitus, Heart failure, Kidney failure",

author = "Nikolaus Marx and Dirk M{\"u}ller-Wieland and Christine Espinola-Klein and Martin Halle and Annette Birkenhagen and Patrick Diemert and Felix Mahfoud and Harm Wienbergen and Katharina Sch{\"u}tt",

note = "Publisher Copyright: {\textcopyright} Deutsche Gesellschaft f{\"u}r Kardiologie - Herz- und Kreislaufforschung e.V. Published by Springer Medizin Verlag GmbH, ein Teil von Springer Nature - all rights reserved 2024.",

year = "2024",

month = jun,

doi = "10.1007/s12181-024-00689-6",

language = "Deutsch",

volume = "18",

pages = "256--265",

journal = "Kardiologie",

issn = "2731-7129",

publisher = "Springer Medizin",

number = "3",

}

TY - JOUR

T1 - Kommentar zu den Leitlinien (2023) der ESC zum Management kardiovaskulärer Erkrankungen bei Patienten mit Diabetes

AU - Marx, Nikolaus

AU - Müller-Wieland, Dirk

AU - Espinola-Klein, Christine

AU - Halle, Martin

AU - Birkenhagen, Annette

AU - Diemert, Patrick

AU - Mahfoud, Felix

AU - Wienbergen, Harm

AU - Schütt, Katharina

N1 - Publisher Copyright: © Deutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung e.V. Published by Springer Medizin Verlag GmbH, ein Teil von Springer Nature - all rights reserved 2024.

PY - 2024/6

Y1 - 2024/6

N2 - Patients with diabetes mellitus exhibit an increased risk for the development of cardiovascular diseases and the presence of both comorbidities has a major impact not only on the prognosis but also the implementation of evidence-based treatment to reduce the cardiovascular risk. The new 2023 guidelines of the European Society of Cardiology (ESC) provide firm evidence-based recommendations for the management of cardiovascular diseases in patients with diabetes. The most relevant aspects of these guidelines are summarized in the following overview article.

AB - Patients with diabetes mellitus exhibit an increased risk for the development of cardiovascular diseases and the presence of both comorbidities has a major impact not only on the prognosis but also the implementation of evidence-based treatment to reduce the cardiovascular risk. The new 2023 guidelines of the European Society of Cardiology (ESC) provide firm evidence-based recommendations for the management of cardiovascular diseases in patients with diabetes. The most relevant aspects of these guidelines are summarized in the following overview article.

KW - Cardiovascular disease

KW - Diabetes mellitus

KW - Heart failure

KW - Kidney failure

UR - https://www.scopus.com/pages/publications/85193329968

U2 - 10.1007/s12181-024-00689-6

DO - 10.1007/s12181-024-00689-6

M3 - Artikel

AN - SCOPUS:85193329968

SN - 2731-7129

VL - 18

SP - 256

EP - 265

JO - Kardiologie

JF - Kardiologie

IS - 3

ER -

Kommentar zu den Leitlinien (2023) der ESC zum Management kardiovaskulärer Erkrankungen bei Patienten mit Diabetes

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this